Volume 9 Supplement 1
Proceedings of 18th Pediatric Rheumatology European Society (PReS) Congress
Meeting abstracts
Edited by Rolando Cimaz, Pavla Dolezalova, Marco Gattorno, Hermann Girschick, Michael Hofer, Sue Maillard, Alberto Martini, Pierre Quartier, Carlos Rose, Johannes Roth, Rebecca ten Cate and Carine Wouters.
18th Pediatric Rheumatology European Society (PReS) Congress. Go to conference site.
Bruges, Belgium14-18 September 2011
Page 3 of 8
-
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P58
-
Inflammatory myositis in the pediatric rheumatology clinical practice – a case series
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P59 -
Calcinosis and lipodystrophy: clinical presentation of 10 years non-treated juvenile dermatomyositis – case report
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P60 -
Development and initial validation of a new functional ability tool for juvenile dermatomyositis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P61 -
Juvenile dermatomyositis (JDM) sine myositis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P62 -
CD4+FOXP3+ regulatory T cells are abundantly present in inflamed muscle of patients with juvenile dermatomyositis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P63 -
Off-label use of biological agents in the management of uveitis: experience from a pediatric rheumatology centre
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P64 -
Mesenchymal stem cells and JIA
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P65 -
Efficacy and safety of Etanercept therapy in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P66 -
Rationale and efficacy of interleukin-1 targeting in pediatric Erdheim- Chester disease
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P67 -
Safety of anti-TNF therapy: 10 year experience in pediatric patients from a single tertiary center
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P68 -
B cells depletion as a value alternative therapeutic in pediatric autoimmune disorders: 3 case reports
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P69 -
Biologicals acting against interleukin 1 may reduce corticosteroid dependence in systemic onset juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P70 -
Anakinra treatment in patients with systemic-onset juvenil idiopathic arthritis: “The Valencia Experience”
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P71 -
Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P72 -
When is a autologous bone marrow transplantation indicated in the treatment of juvenile systemic sclerorsis? Results of a multinational survey of Pediatric Rheumatologist
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P73 -
Preliminary results for 6 minute walk values in healthy German children
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P74 -
Juvenile localized scleroderma: review of 44 patients
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P75 -
Decreased digital skin microvascular blood flow before and after cold stimulus using Laser Doppler imaging in juvenile systemic sclerosis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P76 -
Autologous stem cell transplantation in two children with disabling pansclerotic morphea
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P77 -
Childhood morphea does not impair self-perception
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P78 -
Linear scleroderma en coup the sabre, progressive facial hemiatrophy and Rasmussen encephalitis : a single disease spectrum?
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P79 -
Cutaneous PAN and Common Variable Immunodeficiency: what causes what?
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P80 -
Kawasaki disease in a northern region of Italy
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P81 -
Anti-tumor necrosis factor therapy in children with refractory Takayasu arteritis: report of five cases
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P82 -
Increased serum Interleukin-18 in the active phase of Henoch-Schönlein purpura
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P83 -
Role of CD4+CD25hiCD127lo/-FoxP3+ regulatory T lymphocytes in the pathogenesis of Behçet’s disease in children
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P84 -
Moyamoya disease. An important differential diagnosis to cerebral vasculitis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P85 -
Coronary artery abnormalities in Kawasaki disease according to patient age
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P86 -
An 11-year-old boy with long lasting headaches
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P87 -
Clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in French children
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P88 -
Brazilian multicentre study of Takayasu’s arteritis in children and adolescents – preliminary results of a clinical, imaging and therapeutic study
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P89 -
Cutaneous polyarteriitis nodosa with Grave’s disease and cholestatic liver disease
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P90 -
Imunological and clinical characteristics in children with polyarteritis nodosa: a retrospective study over the last 20 years
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P91 -
Disease activity in paediatric vasculitis: development of a generic assessment tool - PVAS
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P92 -
Primary systemic vasculitis in children in Estonia: a retrospective study from 2001-2010
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P93 -
Primary angiitis of the central nervous system in children - case series
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P94 -
ANCA-associated vasculitides in childhood
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P95 -
Unusual presentations of Churg Strauss syndrome in paediatrics: a tale of 2 masses from one centre experience
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P96 -
Outcome of children with panarteritis nodosa: a series of 30 cases
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P97 -
Recurrent refractory Kawasaki disease
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P98 -
Unusual organ involvment in Henoch–Schönlein purpura patients; a roprt from Iran
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P99 -
Efficacy of abatacept in juvenile idiopathic arthritis related uveitis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P100 -
Sensitivity and specificity of current diagnostic guidelines in children with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P101 -
Low levels of the nerve growth factor receptor TrkA in JIA: a possible defect in a novel anti-inflammatory mechanism
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P102 -
Genetic susceptibility to juvenile idiopathic arthritis in Iranian children
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P103 -
A novel therapeutic approach for macrophage actıvatıon syndrome due to SoJIA
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P104 -
Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P105 -
Comparative characteristic of quality of life with patients suffering from juvenile idiopathic arthritis (JIA), attending school and taught at home
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P106 -
Down regulation of anti-inflammatory cytokines in ileal mucosa associates with active disease in juvenile idiopathic arthritis
Citation: Pediatric Rheumatology 2011 9(Suppl 1):P107
Official journal of
Annual Journal Metrics
-
Citation Impact
3.413 - 2-year Impact Factor (2021)
3.970 - 5-year Impact Factor (2021)
1.315 - Source Normalized Impact per Paper (SNIP)
1.051 - SCImago Journal Rank (SJR)Speed
43 days to first decision for all manuscripts (Median)
53 days to first decision for reviewed manuscripts only (Median)
Usage
917,107 Downloads (2021)
661 Altmetric mentions (2021)